Results 241 to 250 of about 6,596,421 (354)

Personalized medicine—a tradition in general practice!

European Journal of General Practice, 2019
Manfred Maier
doaj   +1 more source

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai, Yang Qu, Reziya Abuduxukuer, Kejia Zhang, Peng Zhang, Xin Tang, Huaimei Zhang, Lijuan Wang, Lichong Yang, Shuangxu Tan, Zhimei Yuan, Ce Han, Lili He, Yuping Zheng, Fenglan Zhao, Lijie Guo, Ligang Jiang, Jinfeng Li, Yongfei Jiang, Xuexia Zou, Dan Xu, Han Xu, Xiaojia Wang, Yingbin Qi, Xuefeng Hu, Yu Zhang, Zhen‐Ni Guo, Hang Jin, on behalf of the Biomarkers of Brain Injury Investigator Study Group   +28 more
wiley   +1 more source

Response to the Letter to the Editor by Dr Koratala et al. [PDF]

Can J Kidney Health Dis
Soret G, Leidi A, Mavrakanas TA.
europepmc   +1 more source

Calculations of Chao1, ACE, Shannon and Good's Coverage indices for treatments with bio-organic fertilizer (BIO), cattle manure compost (CM), Chinese medicine residue compost (CMR), general operation control (GCK) and pig manure compost (PM) at a 97% similarity threshold.

, 2015
Shen ZongZhuan, Dongsheng Wang, Yunze Ruan, Chao Xue, Zhang Jian, Rong Li, Qirong Shen   +6 more
openalex   +2 more sources

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Time-dependent predictive performance of inflammatory markers for 30-day all-cause mortality in patients with suspected infection in a Japanese emergency department: a retrospective cohort study. [PDF]

BMJ Open
Omiya M, Takada T, Yano T, Fujii K, Fujiishi R, Fukuhara S.   +5 more
europepmc   +1 more source

Immunohistochemical Profile, Disease-Free Survival, and Pattern of Recurrence Among Non-Metastatic Breast Cancer Patients of the Philippine General Hospital during the first 5 Years of Implementation of the Department of Health-Breast Cancer Medicine Acce

, 2018
Madeline Amante, Jezraline Marie Cacanindin, Corazon A. Ngelangel, Clarito Cario, Rachel Marie B. Rosario   +4 more
openalex   +1 more source

The application of bifidobacteria strains in the practice of pediatricians and general practitioners of family medicine (literature review)

А.О. Pysariev, A.O. Pysariev
openalex   +2 more sources

The Case of a 28‐Year‐Old Woman With Medically Refractory Focal Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We present the case of a 28‐year‐old right‐handed woman with medically refractory focal epilepsy. Her seizure semiology and electroencephalography (EEG) indicated a seizure onset zone in the right central‐parietal area. However, both MRI and PET scans were unremarkable, showing no focal lesions or areas of altered metabolism.
Rishi Sharma, Ilo Leppik, Thomas Henry, Thaddeus Walczak, Sima Patel, Robert McGovern   +5 more
wiley   +1 more source

Vasilieva I. V., Vermenko A.Yu. Philosophy and General Philosophy of Medicine: study guide. – Kyiv: AUS Medicine Publishing, 2019, 240 p.

Idei, 2019
Valerii Zagorodniuk
doaj   +1 more source